Trial of the Week: PROWESS-SHOCK

Trial of the Week: PROWESS-SHOCK

Up next

2025 ACCP Annual Meeting Recap

2025 ACCP Annual Meeting Recap Reliving the 2025 ACCP Annual Meeting as Conference Correspondent Anthony Hawkins and I recap everything that happened in Minneapolis, MN Special guest: Anthony Hawkins, PharmD, BCCCP, FCCM, FCCP @Pharmacytodose Pharmacytodose@gmail.com Learn more a ...  Show more

2025 ACCP Annual Meeting Highlights: Elevating Clinical Pharmacy in the ICU

2025 ACCP Annual Meeting Highlights: Elevating Clinical Pharmacy in the ICU Highlighting a 2025 ACCP Annual Meeting educational session as well as a financial opportunity available to all Critical Care PRN members. 01:30 – Highlighting the Consensus Recommendations for Integratin ...  Show more

Recommended Episodes

#166 Stress Ulcer Prophylaxis in the ICU and REVISE Trial: Beyond Journal Club with NEJM Group
Core IM | Internal Medicine Podcast

What’s the evidence been for the use of PPIs in mechanically ventilated patients? What do more recent studies reveal about PPIs and possible harmful side effects of aspiration pneumonia and C. difficile colitis? To find out, tune into the second season of Beyond Journal Club, a s ...  Show more

The 2 Minute Medicine® Podcast- Episode 51
The 2 Minute Medicine® Podcast

In the first half of this episode we cover our article of the week which comes from the New England Journal of Medicine and is entitled “Invasive Treatment Strategy for Older Patients with Myocardial Infarction.“ In the second half, we start with a discussion about Jamie Foxx’s h ...  Show more

Sep 26 2025 This Week in Cardiology
This Week in Cardiology

A bold trial in valvular heart disease, a CV prevention trial whose message is humility, VTE dogma challenged, more news on oral GLP-1 agonists, and a few public service announcements are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for ...  Show more

S1 Episode 6: New and Emerging Therapies in HIV Treatment
Medscape InDiscussion: HIV

Drs Michael Saag and Judith Currier discuss options for long-acting HIV therapies, minimizing patient interactions with the healthcare system, and honoring patient preferences. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/vie ...  Show more